Browsing: Investing

Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease. The…

Elon Musk’s X will start charging new, unverified users in a test program in two countries. X, formerly known as Twitter, said Tuesday it will test…

All large cryptocurrencies were down during morning trading on Tuesday, with Uniswap UNIUSD, +0.55% seeing the biggest move, declining 5.12% to $3.93. Polkadot DOTUSD, +0.17% dropped…

Rite Aid Corp.’s stock tumbled 55% Tuesday, falling to 30 cents, after resuming trade following a halt on Monday. The stock was halted after the company…

A previous version misstated the S&P 500’s performance since Sept. 14. It has been updated. Ford Motor Co. Executive Chair Bill Ford has jolted markets by…

Uranium prices have reached their highest level in more than a decade as a global supply shortage persists, with the bull market for uranium investments still…

For many employees, open enrollment for benefits selection occurs between October and November. Selecting from a long list of choices can be overwhelming to say the…

By Sabela Ojea Shares of Pfizer on Friday declined 3.5%, to $31.00, in after-hours trading after the company slashed its outlook for the year amid views…

Key News Asian equities were higher on light volumes as investors kept an eye on the Middle East. Ten state-owned-enterprises (SOEs) announced new or increases to…

By Ben Glickman Pfizer said it would reverse $4.2 billion in revenue after revising its agreement with the U.S. government related to its Covid-19 treatment Paxlovid.…